Indegene Ltd.

Financial

	Indegene	Syngene Internation.	Jubilant Pharmova
Operational Metrics
Software Services
Active Clients	63.0 .	n/a	n/a
Financials
5 yr Average ROE	26.35 %	14.02 %	8.35 %
5yr average Equity Multiplier	1.68	1.65	2.0
5yr Average Asset Turnover Ratio	1.21	0.51	0.59
5yr Avg Net Profit Margin	12.84 %	16.68 %	7.13 %
Price to Book	5.5	5.56	2.79
P/E	35.36	52.99	20.76
5yr Avg Cash Conversion Cycle	89.95 Days	-1572.22 Days	-19.21 Days
Inventory Days	0.0	17.83 Days	81.78 Days
Days Receivable	89.95 Days	50.73 Days	51.11 Days
Days Payable	0.0	-1569.1 Days	173.51 Days
5yr Average Interest Coverage Ratio	24.33	16.65	3.98
5yr Avg ROCE	34.13 %	14.42 %	9.05 %
5yr Avg Operating Profit Margin	19.32 %	29.32 %	18.69 %
5 yr average Debt to Equity	0.15	0.2	0.64
5yr CAGR Net Profit	22.17 %	4.36 %	-38.8 %
5yr Average Return on Assets	15.63 %	8.45 %	4.23 %
Shareholdings
Promoter Holding	0.0	52.74 %	50.68 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	-17.67 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.37 %	14.6 %	3.61 %

Business

	Indegene	Syngene Internation.	Jubilant Pharmova
Product Wise Break-Up	Product Wise Break-Up Enterprise Commercial Solutions 55.9 Enterprise Medical Solutions 28.26 Omnichannel Activation 12.25 CDMO 0 Discovery Services 0 Dedicated Centres 0 0 0 Radiopharmaceuticals 0 Allergy therapy products 0 Active pharmaceutical ingredients 0 India Branded pharmaceuticals 0 Nutritional products 0 Specialty intermediates 0 Life science chemicals 0 0 Solid dosage formulations 0 Others 3.59	Product Wise Break-Up 0 Life science chemicals 0 India Branded pharmaceuticals 0 Nutritional products 0 Specialty intermediates 0 Active pharmaceutical ingredients 0 Omnichannel Activation 0 Solid dosage formulations 0 Contract Research & Contract Manufacturing (CRAMS) 96.59 Discovery Services 0 Enterprise Medical Solutions 0 Allergy therapy products 0 Radiopharmaceuticals 0 Enterprise Commercial Solutions 0 CDMO 0 Dedicated Centres 0 0 Others 3.41	Product Wise Break-Up Contract Manufacturing 16.81 Life science chemicals 0 India branded pharmaceuticals 0.72 Nutritional products 0 Specialty intermediates 0 Active Pharmaceutical Ingredient (API) 9.26 Omnichannel Activation 0 Solid dosage formulations 10.82 0 Discovery Services 0 Enterprise Medical Solutions 0 Anti-allergic 10.21 Radiopharmaceuticals 44.9 Enterprise Commercial Solutions 0 CDMO 0 Dedicated Centres 0 Contract Research and Development Services 6.7 Others 0.58
Location Wise Break-Up	Location Wise Break-Up North America 70.14 Europe 26.8 India 0.68 Rest of the World 0 Japan 0 USA 0 China 0 Americas and Europe 0 Others 2.38	Location Wise Break-Up Americas and Europe 0 China 0 North America 0 India 1.87 Europe 25.15 USA 64.66 Rest of the World 4.9 Japan 0 Others 3.42	Location Wise Break-Up Americas and Europe 90.17 China 0 North America 0 India 2.33 Europe 0 USA 0 Rest of the World 7.5 Japan 0
Operating Profit Break-Up	Operating Profit Break-Up Enterprise Commercial Solutions 57.84 Enterprise Medical Solutions 34.55 Omnichannel Activation 7.6 Generics 0 CDMO Sterile Injectables 0 Allergy Immunotherapy 0 Radiopharma 0 Proprietary Novel Drugs 0 Contract Research and Development 0 Life Science Ingredients 0 Pharmaceuticals 0 Others 0.01	-	Operating Profit Break-Up Pharmaceuticals 0 Contract Research and Development 17.05 Omnichannel Activation 0 CDMO Sterile Injectables 23.64 Enterprise Medical Solutions 0 Life Science Ingredients 0 Radiopharma 32.37 Enterprise Commercial Solutions 0 Allergy Immunotherapy 26.93 Proprietary Novel Drugs 0 Generics 0 Others 0.01
Verticals	Verticals BioPharmaceuticals 94.0 Medical Devices Companies 2.6 Emerging biotech Companies 2.3 Others 1.1	-	-

Indegene Ltd.

SIGN UP FOR FREE